Dexamethasone as an Adjuvant to Bupivacaine in Suprazygomatic Maxillary Nerve Block

• Status: Not yet recruiting
• Trial end date: 2025-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Postoperative pain score, Faces, Legs, Activity, Cry, Consolability (FLACC) is the primary outcome. The secondary outcomes are the first-time requested analgesia, the number of children required analgesia, the total amount of analgesic requirements during first the 24 hours.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Bupivacaine; Dexamethasone

Criteria

Inclusion Criteria:

• Age between 1 and 9 years

• Children scheduled for primary surgery for soft palate cleft or soft and hard palate clefts

• Gender: both

• ASA grade I - II.

• Informed consent.

Exclusion Criteria:

• Parent refusal

• History of developmental delay or mental retardation, which will make observational pain intensity assessment difficult

• Hypersensitivity to any local anesthetics

• Bleeding diathesis

• Children with co-morbid conditions like congenital heart disease, respiratory pathology and central nervous system disorders

• Skin lesions or wounds at the puncture site of the proposed block